First-line treatment patterns among patients with metastatic pancreatic ductal adenocarcinoma in the real-world setting

被引：0
|
作者：
Dennen, Syvart
Harton, Joanna
Cockrum, Paul
Kim, George P.
MacEwan, Joanna P.
机构：
[1] Genesis Res Grp, Hoboken, NJ USA
[2] Ipsen Biopharmaceut Inc, Cambridge, MA USA
[3] Univ Florida, UF Hlth Canc Ctr, Gainesville, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16320
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Real world treatment patterns of first-line combination therapies among BRAF plus metastatic melanoma patients.
    Ghate, Sameer
    Tang, Jackson
    Li, Zhiyi
    Nakasato, Antonio Reis
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [42] Palliative treatment of pancreatic adenocarcinoma in a real-world setting.
    Kordes, Maximilian
    Malgerud, Oscar
    Karimi, Masoud
    Frodin, Jan-Erik
    Liljefors, Maria Gustafsson
    Loehr, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [43] Real-world treatment discontinuation patterns among patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan-based regimens in the United States
    Kim, G.
    Surinach, A.
    Wang, S.
    Lamarre, N.
    Cockrum, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S1107 - S1108
  • [44] Cost-effectiveness of SLOG vs mFOLFIRINOX as the first-line treatment in metastatic pancreatic ductal adenocarcinoma
    Yang, Yi-Hsin
    Wu, Chen-Hao
    Chiang, Nai-Jung
    Shan, Yan-Shen
    Bai, Li-Yuan
    Li, Chung-Pin
    Chen, Jen-Shi
    Chen, Li-Tzong
    ANNALS OF ONCOLOGY, 2022, 33 : S503 - S503
  • [45] Real-World Patterns of First-Line Hydroxyurea Treatment Among Patients with Essential Thrombocythemia in US Community Oncology Practices
    Yu, Jingbo
    Colucci, Philomena
    Paranagama, Dilan Chamikara
    Sivaraman, Smitha
    Atanasov, Pavel
    Hanna, Becky
    Tang, Jackson
    Parasuraman, Shreekant V.
    BLOOD, 2017, 130
  • [46] Real-world first-line treatment patterns and outcomes in patients with locally advanced or metastatic urothelial carcinoma in the United States.
    Chen, Ronald C.
    Mucha, Lisa
    Nimke, David
    Young, Christopher
    Yang, Hongbo
    Liu, Qing
    Greatsinger, Alexandra
    Zhang, Adina
    Wright, Phoebe
    Quicquaro, Christina Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] REAL-WORLD "CHAIR-TIME" BURDEN ASSOCIATED WITH INTRAVENOUS TREATMENT REGIMENS FOR PATIENTS WITH METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
    MacEwan, J.
    Surinach, A.
    Lamarre, N.
    Cockrum, P.
    VALUE IN HEALTH, 2022, 25 (07) : S326 - S326
  • [48] De-escalation and dose density in real-world patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) who received FOLFIRINOX in the first line.
    Dennen, Syvart
    Shao, Anran
    Dennen, Syvart
    Cockrum, Paul
    Paluri, Ravi Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 628 - 628
  • [49] Real-world assessment of changing treatment patterns and sequence for patients with metastatic renal cell carcinoma (mRCC) in the first-line (1L) setting.
    Shah, Neil J.
    Sura, Sneha
    Shinde, Reshma
    Shi, Junxin
    Perini, Rodolfo F.
    Puneet, Singhal
    Robert, Nicholas J.
    Vogelzang, Nicholas J.
    Motzer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [50] Real-world patterns of care among patients with metastatic pancreatic cancer (mPC)
    O'Reilly, Eileen Mary
    Surinach, Andy
    Wu, Zheng
    Cockrum, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345